Streetbeat News

Stock Prices

NXL

Nexalin Technology has announced promising results from a trial indicating that its DIFS technology increases neural activity and blood flow in the hippocampus, potentially offering a new treatment avenue for Alzheimer's disease.

Portfolio Pulse from Benzinga Newsdesk

October 17, 2024 | 12:00 pm

JCI

Johnson Controls Intl (NYSE:JCI) has received 13 analyst ratings over the past three months, with a mix of bullish and bearish perspectives. The average 12-month price target has increased by 10.55% to $76.92. Analysts have raised their ratings and price targets, reflecting positive sentiment. Despite this, the company's financial metrics like net margin, ROE, and ROA lag behind industry averages, indicating potential challenges.

Portfolio Pulse from Benzinga Insights

October 17, 2024 | 12:00 pm

NXL

Nexalin Technology has announced a new study showing that its Deep Intracranial Frequency Stimulation (DIFS) significantly improves memory and cognitive function in Alzheimer's patients. This development could have positive implications for the company's future prospects.

Portfolio Pulse from Benzinga Newsdesk

October 17, 2024 | 12:00 pm

DIS

Jim Cramer expressed interest in buying more shares of Disney if the stock price falls below $90, despite challenges in Disney's theme parks. Disney's experiences unit, including theme parks, now contributes significantly less to the company's income. The company plans a $60 billion investment in its experiences businesses over the next decade.

Portfolio Pulse from Benzinga Neuro

October 17, 2024 | 12:00 pm

PCCE

SOCL

TME

Tencent Music Entertainment Group (NYSE:TME) shares are trading lower on Thursday after announcing a strategic partnership with Galaxy Corporation for G-Dragon's regional tour. This collaboration aims to enhance TME's global presence. TME shares are down 1.90% premarket.

Portfolio Pulse from Lekha Gupta

October 17, 2024 | 11:56 am

LCID

Lucid Group has announced an underwritten offering of 262,446,931 shares, with a corresponding investment by a PIF affiliate, aiming to raise approximately $1.67 billion in gross proceeds.

Portfolio Pulse from Benzinga Newsdesk

October 17, 2024 | 11:53 am

META

QQQ

SPY

Meta Platforms Inc. has initiated layoffs in departments like WhatsApp, Instagram, and Reality Labs as part of internal reorganizations. These layoffs are smaller and department-specific, aligning with Meta's long-term strategy. Despite the layoffs, Meta's stock has gained over 78% in the last 12 months, and the company continues to focus on AI and hardware product development.

Portfolio Pulse from Anusuya Lahiri

October 17, 2024 | 11:52 am

ZVSA

Zyversa Therapeutics' CEO Stephen Glover has issued a letter to shareholders detailing the company's development plans for its inflammasome ASC inhibitor, IC 100, targeting obesity. The letter outlines anticipated milestones over the next nine months.

Portfolio Pulse from Benzinga Newsdesk

October 17, 2024 | 11:52 am

ZVSA

ZyVersa Therapeutics shares rose following a letter from the CEO to shareholders, detailing obesity development plans for their Inflammasome ASC Inhibitor IC 100.

Portfolio Pulse from Benzinga Newsdesk

October 17, 2024 | 11:51 am

NOK

T

VZ

Nokia reported a Q3 earnings miss with an 8% decline in net sales, primarily due to weakness in the Indian market. Despite this, Nokia's net income increased, and the company expects growth in Q4, particularly in Network Infrastructure. Nokia's stock fell 5.16% premarket.

Portfolio Pulse from Anusuya Lahiri

October 17, 2024 | 11:51 am